Depression in community-dwelling elders: Overcoming treatment obstacles with new antidepressants

Postgraduate Medicine

Volumn 103, Issue 3, 1998, Pages 165-174

  VanDerPol, Cristie A ^a   Setter, Stephen M ^a   Hunter, Kimberly A ^a   Pamintuan, Helen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

DEPRESSION; DIAGNOSTIC ERROR; ELDERLY CARE; ENZYME ACTIVITY; FOOD DRUG INTERACTION; HUMAN; NORADRENALIN BLOOD LEVEL; REVIEW; SEROTONIN BLOOD LEVEL; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 0031909129     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.03.419     Document Type: Review

References (19)

1. Fernandez F, Levy JK, Lachar BL, et al. The management of depression and anxiety in the elderly. J Clin Psychiatry 1995;56 Suppl 2:20-9
2. Centers for Disease Control and Prevention. Suicide among older persons: United States, 1980-1992. MMWR 1996; 45(1):3-6
3. Crimson ML, Dorson PG. Schizophrenia. In: DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: a pathophysiologic approach. 3d ed. Stamford, CT: Appleton & Lange, 1997:1381
4. 3 p 1405
5. Reynolds CF 3rd. Depression: making the diagnosis and using SSRIs in the older patient. Geriatrics 1996;51(10):28-34
6. Gram L. Fluoxetine. N Engl J Med 1994;331(20):1354-61 [Erratum, N Engl J Med 1995;332(5):343]
7. Cole JO. New directions in antidepressant therapy: a review of sertraline, a unique serotonin reuptake inhibitor. J Clin Psychiatry 1992;53(9):333-40
8. DeVane CL. Pharmacogenetics and drug metabolism of newer antidepressant agents. J Clin Psychiatry 1994;55 (Suppl 12):38-45; discussion 46-7
9. McEvoy GK, ed. AHFS Drug Information 94. Antidepressants. Bethesda, MD: American Society of Hospital Pharmacists Inc, 1994:1405
10. Luvox product monograph. Marietta, GA: Solvay Pharmaceuticals, Jan 1995
11. USP DI: Volumes I and II update. Rockville, MD: United States Pharmacopeial Convention Inc, 1995:700
12. Serzone product monograph. Princeton, NJ: Bristol-Myers Squibb, May 1996
13. Ellingrod VL, Perry PJ. Nefazodone: a new antidepressant. Am J Health Syst Pharm 1995;52(24):2799-812
14. Ellingrod VL, Perry PJ. Venlafaxine: a heterocyclic antidepressant. Am J Hosp Pharm 1994;51(24):3033-46
15. Richelson E. Pharmacology of antidepressants: characteristics of the ideal drug. Mayo Clin Proc 1994;69(11):1069-81
16. Settle EC Jr. Bupropion: general side-effects. J Clin Psychiatr Monogr 1993; 11(1):33-9
17. Stoudemire A. Expanding psychopharmacologic treatment options for the depressed medical patient. Psychosomatics 1995;36(2):S19-26
18. Kehoe WA, Schorr RB. Focus on mirtazapine: a new antidepressant with nonadrenergic and specific serotonergic activity. Formulary 1996;31(June):455-469
19. Sisten JMA, Moors J. Mirtazapine: a novel antidepressant in the treatment of anxiety symptoms. Results from a placebo-controlled trial. Drug Invest 1994;8(6): 339-44